Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qin Sun

Showing results (831-840 of 835) with videos related to

Pageof 84
Sort By:
You have reached the last page of results.This site can display upto 835 results.
Journal of Medicinal Chemistry|January 10, 2018
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 AgonistsJun Shi, Zhengxiang Gu, Elizabeth Anne Jurica, et al.
Bioorganic & Medicinal Chemistry|April 8, 2023
Optimization of physicochemical properties of pyrrolidine GPR40 AgoPAMs results in a differentiated profile with improved pharmacokinetics and reduced off-target activitiesElizabeth A Jurica, Ximao Wu, Kristin N Williams, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.
Medcomm|November 27, 2025
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter StudyJing Zhao, Ferenc E Mózes, Xin-Yu Xu, et al.
Hepatology International|June 15, 2024
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver diseaseHuai Zhang, Giovanni Targher, Christopher D Byrne, et al.
Pageof 84

Showing results (831-840 of 835) with videos related to

Sort By:
Pageof 84
You have reached the last page of results.This site can display upto 835 results.
Journal of Medicinal Chemistry|January 10, 2018
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 AgonistsJun Shi, Zhengxiang Gu, Elizabeth Anne Jurica, et al.
Bioorganic & Medicinal Chemistry|April 8, 2023
Optimization of physicochemical properties of pyrrolidine GPR40 AgoPAMs results in a differentiated profile with improved pharmacokinetics and reduced off-target activitiesElizabeth A Jurica, Ximao Wu, Kristin N Williams, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.
Medcomm|November 27, 2025
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter StudyJing Zhao, Ferenc E Mózes, Xin-Yu Xu, et al.
Hepatology International|June 15, 2024
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver diseaseHuai Zhang, Giovanni Targher, Christopher D Byrne, et al.
Pageof 84